Mar 1, 2024 · Erbitux is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Erbitux is used to treat cancers of the colon and rectum. It is also used to treat head and neck cancer. Erbitux is often used in combination with other cancer medicines or radiation treatment.

Learn about ERBITUX, a treatment for metastatic colorectal cancer as well as certain types of head and neck cancers.

Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. [2] Cetuximab is a chimeric (mouse/human) monoclonal antibody given by …

ERBITUX, as a single agent, is indicated for the treatment of patients with recurrent or metastatic SCCHN for whom prior platinum-based therapy has failed. ERBITUX has FDA approved weekly and bi-weekly dosing schedules as a single-agent or in combination with platinum-based therapy and fluorouracil. Choose an appropriate option for your patients

Cetuximab is a medication that treats colorectal cancer. This type of cancer develops from polyps (growths) in your colon’s inner lining. Cetuximab can also treat head and neck cancer. A healthcare provider will give you this infusion into your vein in a hospital or clinic. What is this medication? CETUXIMAB (se TUX i mab) is a monoclonal antibody.

Oct 16, 2024 · Erbitux (cetuximab) is a prescription drug that treats certain types of head and neck and colorectal cancers. Erbitux comes as a solution that you receive as an infusion into your vein....

WHAT IS ERBITUX? Erbitux® (cetuximab) is an epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) approved to treat two different types of cancer: RAS wild-type metastatic colorectal cancer (mCRC) and squamous cell cancer of the head and neck (SCCHN).1 Erbitux® (cetuximab) May 2017 Merck Oncology PROGNOSIS

Aug 7, 2024 · Erbitux (cetuximab) is a prescription injection that can be used to treat certain colorectal and head and neck cancers. Learn more about its dosage, side effects, uses, and more.

Jul 25, 2024 · ERBITUX ® is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of: Head and Neck Cancer. Locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy. (1.1, 14.1)

This page contains brief information about cetuximab (Erbitux) and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.